KRC-00715

• Target :

  C-Met/HGFR

• Related Pathways :

  Tyrosine Kinase/Adaptors

• Bioactivity :

  KRC-00715 is an orally effective inhibitor of c-Met, exhibiting high selectivity with an IC50 of 9.0 nM. This compound specifically inhibits the growth of gastric cancer cell lines with high c-Met expression by inducing G1/S phase block, and reduces the activity of downstream signals, including Akt, Erk, and c-Met itself. In the gastric cancer cell line Hs746T, KRC-00715 demonstrates cytotoxicity with an IC50 of 39 nM and selectively inhibits the proliferation of cell lines that overexpress c-Met. Additionally, KRC-00715 decreases tumor size in Hs746T xenograft mouse models.

• Smiles :

  FC(F)(F)C=1C=C(C=CC1OCCN2CCOCC2)C3=NC4=C(N=NN4CC5OC6=CC=CN=C6NC5)N=C3

• Molecular Formula :

  C25H25F3N8O3

• Molecular Weight :

  542.51

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2079853-72-6